Dr. Rosengart has served as a member of PAVmed’s Medical Advisory Board since November 2014. Dr. Rosengart has served as Professor and Chairman of the Michael E. DeBakey Department of Surgery at the Baylor Medical College since November 2012. He also holds the DeBakey-Bard Chair of Surgery, and is Professor of Heart and Vascular Disease at the Texas Heart Institute. He previously served as Professor and Chairman of the Department of Surgery, Chief of Cardiothoracic Surgery, Chairman of Surgery and Co-Director of the Heart Center at The Stony Brook University Medical Center and SUNY-Stony Brook. Prior to that he served as the Owen L. Coon Chair of Cardiothoracic Surgery and Professor of Surgery at Evanston Northwestern Healthcare and Northwestern University and as Associate Professor of Cardiothoracic Surgery at Weill Cornell Medical College, Associate Attending Cardiothoracic Surgeon at New York Presbyterian Hospital and Visiting Associate Professor of Surgery at Columbia University.

Dr. Rosengart has served in leadership roles in various professional societies including the American Heart Association, the Society of Thoracic Surgeons and the American Association of Thoracic Surgery. He serves as editor of Seminars in Thoracic and Cardiovascular Surgery and has served on the editorial boards of various leading medical journals. Dr. Rosengart has had a productive academic career focused on arteriogenesis and gene therapy. He runs an NIH-funded laboratory in this area, has received over $10 million in research grants and published over 100 peer-reviewed publications. He has played an active role in life sciences innovation, serving as an advisor to various medical device and pharmaceutical companies including Abbott, Arrow, St. Jude, J&J/Ethicon, Astra Zeneca and The Medicines Company. He holds 10 issued patents and has co-founded five companies in the medical device and healthcare IT industries.

Dr. Rosengart completed his general surgical training at New York University Medical Center, served as a Fellow in the Surgery Branch of the National Heart, Lung and Blood Institute and completed his cardiothoracic surgical training at The New York Hospital at Cornell Medical College. He received additional surgical training at The Hospital for Sick Children, Great Ormond Street and The Harley Street Clinic, both in London. Dr. Rosengart has been repeatedly recognized as one of America’s Top Doctors in the Castle Connolly Guide. Dr. Rosengart received his B.S. and M.D., both with distinction, from Northwestern University.

Dr. Murphy has served as a member of PAVmed’s Medical Advisory Board since November 2014. Dr. Murphy, an academic interventional radiologist, was Professor of Diagnostic Imaging and Director of the Vascular Disease Research Center at the Warren Alpert Medical School of Brown University from 2005 to 2018.

Since 1992 he has served in various leadership roles at the Society of Interventional Radiology (SIR), the largest interventional radiology society in the world, including Member of the Executive Committee (since 2003) and President of the Society in 2011. He has served in leadership roles in various other professional societies including the American College of Radiology (since 1998) and the American Heart Association (since 1992). Dr. Murphy has had a productive academic career with over 250 publications and leadership roles in several NIH-funded multi-center clinical trials (CORAL, CLEVER and ATTRACT). He served on the Editorial Board of the Journal of Vascular and Interventional Radiology from 1998 to 2009 and as a reviewer for various other leading journals. He has served on multiple NIH study sections and data safety monitoring board. Dr. Murphy has been active in the life sciences innovation, serving as a consultant to Abbott Laboratories, Guidant, Genentech, Bayer and Terumo. He holds patents in stent graft technology, bariatric interventional radiology, and fluid drainage systems, and has co-founded four medical device companies.

Dr. Murphy completed his radiology residency as well as his vascular and interventional radiology fellowship at Brown University School of Medicine’s Rhode Island Hospital. He received his B.A. and M.D., cum laude, from Boston University and received an honorary M.A. degree from Brown University.

Dr. Steig has served as a member of PAVmed’s Medical Advisory Board since January 2015. Since 2000, Dr. Stieg has served as Professor and Chairman of Neurological Surgery at Weill Cornell Medical College, and Neurosurgeon-in-Chief and Chairman of Neurological Surgery at New York-Presbyterian Hospital. During this same period, he has also served as Professor of Neurosurgery and Attending Neurosurgeon at the Hospital for Special Surgery and at Memorial Sloan Kettering Hospitals in New York. In 2013, he founded and currently serves as Chairman of the Weil Cornell Brain and Spine Center.

In 2010 Dr. Stieg launched the Weill Cornell Surgical Innovations Lab. From 1989 to 2000, he served as Associate Professor of Surgery at Harvard Medical School and Associate Attending Neurosurgeon at Brigham and Women’s Hospital, Massachusetts General Hospital and Boston Children’s Hospitals in Boston.

Dr. Stieg has served in leadership positions at national and international professional societies, including Chairman of the American Association of Neurological Surgery/Congress of Neurological Surgeons (AANS/CNS) Joint Section on Cerebrovascular Surgery (2004-2005) and President of the Society of University Neurosurgeons (2001-2002). He serves as Editor for the journals Neurosurgery and World Neurosurgery.

Dr. Stieg has had a productive academic career focused on cerebral protection, neural transplantation and neuronal regeneration. He has published over 100 peer-reviewed publications, numerous abstracts, books and manuscripts. He has lectured and served as a visiting professor at leading institutions around the world. He serves as co-principal investigator for StrokeNet, an NIH initiative to conduct Phase I/II and III trials in stroke prevention, treatment and recovery. He has served as a consultant to several medial technology companies including Zeiss Optical, Codman (Johnson and Johnson), LifeCell, Diacrin and Medtronic. He has been an advisor to the Department of Defense and the National Football League on brain trauma.

Dr. Stieg received his neurosurgical training at the University of Texas Southwestern Medical School (Parkland Memorial Hospital) and completed a fellowship in cell transplantation for restorative neurological function at the Karolinska Institute in Stockholm, Sweden.Dr. Stieg has been repeatedly recognized as one of America’s Top Doctors in the Castle Connolly Guide. He received his B.S. from the University of Wisconsin at Madison, his Ph.D. in Anatomy and Neuroscience from Albany Medical College of Union University, and his M.D. from the Medical College of Wisconsin.

Dr. Christopher Hartnick has served as a member of PAVmed’s Medical Advisory Board since November 2016.  Dr. Hartnick is also a medical device innovator. His breakthroughs have led to the revolutionary resorbable ear tube technology that PAVmed is developing and commercializing.

Dr. Hartnick is an accomplished otolaryngologist.  He currently serves is the Director of the Pediatric Otolaryngology Division and the Director of the Pediatric Airway, Voice, and Swallowing Center at Massachusetts Eye and Ear.

Dr. Hartnick has been a professor at Harvard Medical School since 2001. Earlier that same year, he received his Masters of Science in epidemiology from the Harvard T.H. Chan School of Public Health. Previously, he completed his fellowship training in pediatric otolaryngology at Cincinnati’s Children’s Hospital. He performed his general surgery residency in 1995 and his otolaryngology residency in 1999, both at the Montefiore Medical Center in New York. Prior to this, Dr. Hartnick earned his medical degree in 1994 from the Albert Einstein College of Medicine.  He earned his undergraduate degree from Princeton University.

Dr. Hartnick has authored 144 peer-reviewed publications He serves as the Physician Director on the Mass. Eye and Ear Board of Directors and is the Vice Chair of Clinical Trials and Outcomes for the Department of Otolaryngology. He is an editor for ENT Journal, a reviewer for Journal of Voice, and an ad-hoc reviewer for several other publications.

Dr. Gerdisch has served as a member of PAVmed’s Medical Advisory Board since November 2014. Dr. Gerdisch is Chief of Cardiovascular and Thoracic Surgery at the Franciscan St. Francis Health Heart Center in Indianapolis, Indiana and Clinical Assistant Professor of Cardiovascular and Thoracic Surgery at the Loyola University Medical Center in Chicago. He has played an active role in various professional societies including the 21st Century Cardiothoracic Surgery Society, serving as its president in 2013.

He has served as a lead investigator on several multi-center clinical trials in the areas of atrial fibrillation and tissue regeneration. Dr. Gerdisch has played an active role in medical device innovation, particularly in the area of heart valves. He has served on the advisory boards of various medical device companies including CorMatrix, Atricure, Medtronic, Edwards Lifesciences and On-X Life Technologies. He received the Excellence in Health Science Research Award at the 2010 Tony and Mary Hulman Awards and was honored as a “Health Care Hero” by the Indianapolis Business Journal in 2010.

Dr. Gerdisch completed his general and cardiothoracic surgical training at Loyola University Medical Center. He was awarded the Keeley Fellowship pursuant to which he received additional training in mitral valve repair and biomechanical assist devices at L’Hopital Broussais in Paris. Dr. Gerdisch has been repeatedly recognized as one of America’s Top Doctors in the Castle Connolly Guide. Dr. Gerdisch received his B.S., with honors, from Loyola University and his M.D. from Loyola University Strich School of Medicine.

Dr. Chin has served as a member of PAVmed’s Medical Advisory Board since January 2015. Dr. Chin is a prominent medical device inventor and serves as a co-founding Partner and Chief Innovation Officer at Pavilion Medical Innovations. He is a principal at PMI portfolio companies Saphena Medical and Cruzar Medsystems and at nVision Medical and ChemoFilter, two additional early stage medical device companies.

From 1994 to 2009, he served as Vice President of Research and Chief Innovation Officer at Guidant Cardiac Surgery, which later became Maquet Cardiovascular. In 1989 he co-founded Origin Medsystems, which was acquired in 1994 by Eli Lilly for $150 million and subsequently spun out as part of Guidant. Prior to that, he worked with medical device entrepreneur Dr. Thomas Fogarty. Dr. Chin has 184 issued patents and 12 commercialized products spanning cardiac, vascular, orthopedic, gynecologic, urologic and general surgery. These include the Fogarty-Chin Linear Extrusion Catheter (Edwards Lifesciences, 1983), the HeartString Aortic Seal (Guidant 2003, now Maquet) and the VenaPax (Saphena Medical, 2014). His products have generated over $3.0 billion in revenue and have been used in millions of patients. The VasoView Endoscopic Vessel Harvest (Guidant 1996, now Maquet) device is the standard of care for the removal of the saphenous vein for use in coronary bypass surgery.

Dr. Chin has 54 peer-reviewed publications and has lectured around the world on his inventions and innovation in general. In 2007, he received the Stanford University, Emerging Entrepreneurs in Biomedical Technology, Ideals of Entrepreneurship Award. He serves as a mentor in the T1 Catalyst Program at the University of California San Francisco. Dr. Chin received his surgical training at the University of Texas Southwestern Medical School (Parkland Memorial Hospital). He received his B.S. in Mechanical Engineering from MIT, his M.S. in Mechanical Engineering from Stanford University and his M.D. from the University of California San Francisco School of Medicine.

Dr. Engelman is the Medical Director of the Heart, Vascular and Critical Care Units at Baystate Medical Center.  He is an Associate Professor of Surgery at The University of Massachusetts-Baystate, and an Associate Professor-Adjunct at Tufts University School of Medicine. He recently started the Enhanced Recovery After Cardiac Surgery (ERACS) Collaborative to nationally standardize best practices and is the first author of the international guidelines on perioperative cardiac surgical best practice, recently published in JAMA Surgery. He is the President of the Massachusetts Society of Thoracic Surgeons and also serves on multiple Statewide Oversight committees. Dr. Engelman participates on two national workforces for the Society of Thoracic Surgeons and was the Past President of the 21^st Century Cardiothoracic Surgical Society. He also serves on the Board of Directors of the Baycare PPO and ACO and is Vice President of the local Independent Physician Organization.

Dr. Engelman is the principal investigator on multiple research projects, has published over 40 peer-reviewed publications, and participates on an international taskforce standardizing approaches for the prevention of postoperative acute kidney injury. He travels extensively lecturing on advances in critical care medicine, healthcare informatics and finance, multimodal analgesia, and fast-track recovery after cardiac surgery. He serves as a consultant, independent medcial reviewer and speaker for Mallinckrodt pharmaceuticals, Edwards Lifescience, Zimmer-Biomet, and Astute Medical.  He was named the National ACS/STS Health Policy Scholar in 2016.

Dr. Engelman is a graduate of the Executive Leadership Program in Health Policy and Management at The Heller School of Brandeis University. He was a Research Fellow at the University of Connecticut School of Medicine. He completed his cardiothoracic Surgical training at Brigham & Women’s Hospital in Boston. He received his B.A. with honors from the University of Pennsylvania and M.D. from New York University School of Medicine.